Sign Up Today and Learn More About Iterative Health Stock
Invest in or calculate the value of your shares in Iterative Health or other pre-IPO companies through EquityZen's platform.
Iterative Health Stock
Iterative Health develops technology that can benefit patients anywhere, regardless of socioeconomic or geographic barriers.
About Iterative Health Stock
Founded
2017
Headquarters
Cambridge, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Iterative Health Press Mentions
Stay in the know about the latest news on Iterative Health
Iterative Health Acquires Cardiology Sites from NextStage Clinical Research
businesswire • May 14, 2026
There’s a big new AI startup in town. Meet Blitzy and its Boston investors.
bostonglobe • May 06, 2026
Iterative Health Reports Expanded Trial Performance Data at Digestive Disease Week 2026, Demonstrating Consistent Outperformance of Industry Benchmarks at Double the Scale
businesswire • May 04, 2026
The Week’s 10 Biggest Funding Rounds: Defense Tech Leads With Multiple Large Deals, Topped By $600M For Space Security Startup True Anomaly
news • May 03, 2026
Iterative Health Reaches Unicorn Status with $77 Million Series C
startupresearcher • May 02, 2026
Iterative Health Management
Leadership team at Iterative Health
Founder & CEO
Jonathan Ng
President and Chief Financial Officer
Bill Kayser
Join now and verify your accreditation status to gain access to:
- Iterative Health Current Valuation
- Iterative Health Stock Price
- Iterative Health Management
- Available deals in Iterative Health and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Iterative Health Cap Table and Funding History by Share Class and Liquidity Preferences
- Iterative Health Revenue and Financials
- Iterative Health Highlights
- Iterative Health Business Model
- Iterative Health Risk Factors
- Iterative Health Research Report from SACRA Research
Trading Iterative Health Stock
How to invest in Iterative Health stock?
Accredited investors can buy pre-IPO stock in companies like Iterative Health through EquityZen funds. These investments are made available by existing Iterative Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Iterative Health stock?
Shareholders can sell their Iterative Health stock through EquityZen's private company marketplace. EquityZen's network includes over 450K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."